Switch to:
More From Other Websites
Most active Nasdaq-traded stocks Sep 30 2014
[video] Zafgen CEO: 2015 Will Be Data Rich Year for Obesity Treatment Sep 30 2014
VIVUS and Auxilium Announce Stendra Label Expansion Sep 19 2014
VIVUS Inc. (VVUS) Rises: Stock Adds 12.4% in Session Sep 19 2014
Rite Aid and Pier 1 are big market movers Sep 18 2014
Rite Aid and Pier 1 are big market movers Sep 18 2014
UPDATE 1-Vivus' Stendra gets FDA approval for use 15 minutes before sex Sep 18 2014
US STOCKS-Banks rally on rate outlook, lead S&P 500 to new high Sep 18 2014
FDA OKs faster-acting label for ED drug Stendra Sep 18 2014
FDA OKs faster-acting label for ED drug Stendra Sep 18 2014
VIVUS, Inc.’s Stendra lets you get it up faster Sep 18 2014
[$$] Stendra Gets FDA Approval as 'On-Demand' Drug Sep 18 2014
Why VIVUS (VVUS) Stock Is Up Today Sep 18 2014
Vivus, Inc. Opens Sharply Higher On ED Drug Marketing Approval Sep 18 2014
US STOCKS-Wall Street set to open higher, S&P 500 eyes record Sep 18 2014
Pharmalot, Pharmalittle: We're Reading About Vivus, Gilead and Lots More!! Sep 18 2014
VIVUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 18 2014
VIVUS and Auxilium Announce FDA Approval of STENDRA sNDA; STENDRA Now First and Only Oral Erectile... Sep 18 2014
VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile... Sep 18 2014
VIVUS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Sep 16 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK